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reported include confrontation naming, syntactic 
comprehension and verb processing (8–11). Although 
there is some clinical utility in using standardized 
tests, this approach oversimplifies the complexity of 
the linguistic data as these tests do not evaluate 
functional language skills such as discourse.
Recent work has documented deficits in the ability 
of ALS patients to organize the local connectedness 
and maintenance of the theme during narrative dis-
course (12). However, the specific nature of these 
deficits in ALS is not yet clear. This is critical because 
spontaneous connected speech is an essential part of 
everyday communication. Features of connected 
speech in ALS have only been investigated by one 
recent study that reported a deficit in grammatical 
Introduction
There is currently great interest in characterizing 
the cognitive profiles of patients with amyotrophic 
lateral sclerosis (ALS) who do not meet criteria for 
frontotemporal lobar degeneration (FTLD) (1). 
Considering that degeneration in ALS affects primar-
ily posterior frontal regions, this line of research has 
mainly focused on the presence of executive func-
tions (e.g. (2–4)). Nevertheless, in recent years 
research has shown that cognitive deficits go beyond 
an executive dysfunction syndrome and reveal that 
language is also affected (5–7). A variety of structured 
language tests have been used to detect linguistic 
impairment in ALS and the most common changes 
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Abstract
Despite recent interest in cognitive changes in patients with amyotrophic lateral sclerosis (ALS), investigations of language 
function looking at the level of word, sentence and discourse processing are relatively scarce. Data were obtained from 26 
patients with sporadic ALS and 26 healthy controls matched for age, education, gender, anxiety, depression and executive 
function performance. Standardized language tasks included confrontation naming, semantic access, and syntactic 
comprehension. Quantitative production analysis (QPA) was used to analyse connected speech samples of the Cookie 
Theft picture description task. Results showed that the ALS patients were impaired on standardized measures of grammatical 
comprehension and action/verb semantics. At the level of discourse, ALS patients were impaired on measures of syntactic 
complexity and fluency; however, the latter could be better explained by disease related factors. Discriminant analysis 
revealed that syntactic measures differentiated ALS patients from controls. In conclusion, patients with ALS exhibit deficits 
in receptive and expressive language on tasks of comprehension and connected speech production, respectively. Our 
findings suggest that syntactic processing deficits seem to be the predominant feature of language impairment in ALS and 
that these deficits can be detected by relatively simple language tests.
Key words: Cognition, language, speech, amyotrophic lateral sclerosis
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expression (13). The present study aimed to build on 
these recent findings (13) and improve the 
characterization of connected speech production and 
other language functions in ALS. A secondary aim was 
to examine the potential of formal standardized lan-
guage testing and spontaneous speech analysis in the 
identification of a specific linguistic marker for ALS.
Materials and methods
Participants
Twenty-six patients with sporadic ALS and 
26 healthy controls participated in the study. 
ALS patients were mainly recruited from 
The King’s Motor Neurone Disease (MND) Care 
and Research Centre, London, UK. Additional 
patients were recruited from Barts Health Motor 
Neurone Disease Centre in London and from the 
Motor Neurone Disease Association (MNDA) 
research register. Healthy control participants 
were recruited through a volunteer database and 
the local community.
Inclusion criteria for all participants were age  75 
years, English as a first language, right handedness, 
no history of cerebrovascular disease, hypertension, 
diabetes or head injury, not taking any psychoactive 
medication and IQ  70. We included patients with 
probable or definite ALS (14) within 24 months 
after diagnosis. Patients with bulbar symptoms 
(ALSFRS-R (15) score on bulbar items 1–3,  9), 
respiratory insufficiency (FVC  70% predicted), 
and insufficiently intelligible speech were excluded. 
Additional patient exclusion criteria included a 
clinical diagnosis of Frontotemporal Dementia 
(FTD), Primary Progressive Aphasia (either pro-
gressive non-fluent aphasia (PNFA) or semantic 
dementia (SD)) – according to FTLD diagnostic 
criteria (16). Control participants were matched as 
closely as possible to the ALS group for age, gender 
and education.
Measures
Patients’ functional abilities were assessed using the 
revised Amyotrophic Sclerosis Functional Rating 
Scale (ALSFRS-R) (15). The Wechsler Abbreviated 
Scale of Intelligence (WASI) (17) and Wechsler Test 
of Adult Reading (WTAR) (18) were used to assess 
current and premorbid IQ, respectively. Symptoms 
of anxiety and depression were measured using the 
Hospital Anxiety and Depression Scale (HADS) 
(19). The Family Form of the Frontal System Behav-
iour Scale (FrSBe) was used to assess behavioural 
changes (20), characterized as scores on subscales of 
Apathy, Executive Dysfunction and Disinhibition.
The neuropsychological data for the present study 
included a broad battery of tests assessing executive 
function, visuoperceptual ability, memory and lan-
guage. To determine differences in cognitive function-
ing outside the language domain between patients 
with ALS and healthy controls, composite scores were 
calculated for the Executive, Visuoperceptual and 
Memory domains (Table I). This was undertaken 
with the aim of reducing the likelihood of making type 
1 errors through multiple comparisons using each 
individual neuropsychological test score, following the 
methods described by Taylor et al. (6).
Formal standardized language testing included 
measurements of confrontation naming, semantic 
access, and single word and syntactic comprehen-
sion. Confrontation naming was measured with the 
Graded Naming Test (21). Semantic access of nouns/
objects and verbs/action was measured by the Pyra-
mids & Palm Trees (22) and the Kissing & Dancing 
Tests (22), respectively. Syntactic and single word 
comprehension was assessed with the Test of Recep-
tion of Grammar (24), the modified Token Test (25) 
and the British Picture Vocabulary Scale-II (26).
The connected speech sample was taken from the 
Cookie Theft picture description component of the 
Boston Diagnostic Aphasia Examination (33). Quanti-
tative production analysis (QPA) (34) was used to 
Table I. Test indices included in cognitive composites.
Domain
Measures contributing to the composite (scores reflected where necessary so that higher composite 
scores indicated greater impairment).
Executive functioning Phonemic Verbal Fluency Index (VFi) (3): Words beginning with ‘S’ produced in 5 min and 4-letter 
words beginning with ‘C’, produced in 4 min adjusted for motor disability.
Semantic VFi (3): ‘Animal’ and ‘Food’ words, adjusted for motor disability produced in 2 min, 
respectively.
Hayling Sentence Completion Test (27): Latency score (i.e. the difference between the time taken to 
complete both sections of the test, ‘Unconnected Sentences’ total time’ – ‘Sensible Completion’ total 
time).
Test of Everyday Attention (28): Telephone search dual-task decrement score.
Computerized Wisconsin Card Sorting Test (WSCT) (29): Categories achieved, trials to first category
Composite’s Cronbach’s alpha  0.664
Memory California Verbal Learning Test (CVLT) (29): free recall, short-delay free recall, long-delay free 
recall, long-delay cued recall scores
Composite’s Cronbach’s alpha  0.771
Visuoperceptual Ability Visual Object and Space Perception Battery (VOSP) (30): total number of errors on object decision 
and position discrimination subtests.
Judgment of Line Orientation (JLO) (31): total numbers of errors
Composite’s Cronbach’s alpha  0.617
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analyse the transcribed language samples following the 
approach used by Wilson et al. (35). Transcripts were 
coded by two graduates trained in analysis of recorded 
discourse, blind to participants’ status. Coding showed 
high inter-rater reliability (correlations ranged from .85 
to .93) with the exception of phonological distortions, 
paraphasias and semantic errors. The identification of 
distortions and semantic errors has been found to be 
the most problematic aspect of coding (35). Distor-
tions were defined as articulatory speech errors that did 
not involve frank phonemic substitutions. For patients 
with dysarthria, every word could potentially be classi-
fied as a distortion, so for these patients only words that 
were distorted above a patient’s most accurate speech 
were coded as distortions. Semantic errors were 
recorded when participants produced sentences that 
were syntactically well-formed, but were either non-
sensical or were semantically inappropriate for the con-
text. The most common type of semantic errors involved 
substitutions of semantically related items. Discrepan-
cies in coding were resolved following advice from a 
speech and language therapist.
The linguistic profile of connected speech produc-
tion assessed measures under four main categories: 1) 
speech production (numbers of words, duration of nar-
ratives, speech rate, distortions and phonological para-
phasias); 2) disruptions to fluency (false starts, filled 
pauses, repaired sequences and incomplete sentences); 
3) lexical content (proportional frequencies of closed 
class words, pronouns and verbs); and 4) syntactic 
structure and complexity (mean length of utterances, 
proportional frequencies of words in sentences, num-
ber of embeddings, and semantic errors).
Ethics approval for the study was obtained from 
The Joint South London and Maudsley and The 
Institute of Psychiatry NHS Research Ethics Com-
mittee (07/H0807/85). Appropriate institutional 
approvals were obtained to permit recruitment from 
additional centres. Informed written consent was 
obtained from all participants, consistent with the 
Declaration of Helsinki.
Statistical analysis
The data were analysed using Statistical Package for 
the Social Sciences (SPSS) Version 21. Variables were 
checked for normality and homogeneity assumptions 
of parametric tests. Between-group comparisons were 
undertaken using t-tests or multivariate analysis of 
covariance (MANCOVA). Categorical data were 
analysed using c2 tests. Pearson’s correlations and 
discriminant function analyses were used to examine 
the relationships between language scores and clini-
cal measures. All tests were two-tailed and statistical 
significance was set at p  0.05.
Results
Background characteristics
Demographic and clinical characteristics of partici-
pants are summarized in Table II. The mean 
ALSFRS-R score at the time of neuropsychological 
assessment was 40.38 (SD, 4.16). Eighty-five percent 
of patients had limb onset and 15% had bulbar-
onset disease, with an average delay from symptom 
onset to diagnosis of approximately 10 months 
(M  9.26, SD  7.8). Seventy-six percent of ALS 
patients were taking riluzole at the time of assess-
ment. There were no significant differences between 
the groups in terms of age, education, gender ratio, 
current IQ or estimated premorbid IQ, current 
FrSBe subscale scores as rated by informants, or 
HADS anxiety and depression scores. The groups 
also did not differ in terms of their executive func-
tion, memory or visuoperceptual performance as 
measured by composite score domains.
The specificity of interpretations drawn from this 
study may be restricted by the use of cognitive 
Table II. Demographic and clinical characteristics of participants and composite scores.
Mean (SD)
ALS Controls t (df)/ c2 (df) p
Gender, n (%) Male 23 (88%) 20 (74%) 1.229 (1) 0.268
Age (years) 52.98 (12.13) 48.06 (8.70) 21.678 (50) 0.100
Education (years) 13.43 (3.82) 14.80 (4.46) 1.197 (50) 0.237
HADS Depression 2.04 (2.34)
(Median  1)
1.88 (2.25)
(Median  1)
22.42 (50) 0.810
HADS Anxiety 2.73 (2.67)
(Median  2)
3.84 (3.30)
(Median  2)
1.337 (50) 0.187
Current IQ (WASI) 114.18 (14.50) 118.04 (11.28) 1.035 (47) 0.306
Premorbid IQ (WTAR) 111.42 (6.79) 114.84 (7.17) 1.767 (50) 0.083
FrSBe apathy* 48.05 (9.88) 46.13 (12.54) 20.567 (43) 0.574
FrSBe disinhibition* 50.59 (11.61) 50.91 (11.61) 0.095 (43) 0.925
FrSBe executive dysfunction* 49.23 (9.99) 46.82 (10.20) 20.791 (43) 0.434
Executive function composite 20.47 (2.5) 0.01 (1.05) 0.928 (50) 0.358
Memory composite 20.34 (0.83) 0.01 (0.85) 1.556 (50) 0.126
Visuoperceptual composite 20.29 (1.68) 0.01 (0.70) 0.865 (50) 0.391
*T score HADS: Hospital Anxiety and Depression Scale; WASI: Wechsler Abbreviated Scale of 
Intelligence; WTAR: Wechsler Test of Adult Reading; FrSBe: Frontal Systems Behaviour Scale.
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composite scores derived from varied assessment 
measures. Although this method avoids type 1 errors 
and allows a more global interpretation based on 
overall rates of impairment in executive and other 
domains, further details of scores on individual mea-
sures (Table III) provide additional information con-
cerning the profiles of cognitive impairment. 
Individual measures of executive, memory and visuo-
perceptual functioning did not differ between ALS 
patients and controls, with the exception of TEA 
dual decrement (p  .049), the WCST categories 
achieved (p  .052) and CVLT short- 
delay recall (p  .058) which showed marginal 
differences. These data were not used further in this 
study. However, after individual inspection of the 
data, four patients with ALS exhibited impaired 
phonemic verbal fluency (VFi). These patients scored 
at least 2 SDs below the mean score of healthy 
controls on two tests of phonemic verbal fluency.
Connected speech measures
The performance on measures of connected speech 
production of ALS patients and healthy controls was 
compared using multivariate analyses of covariance 
(MANCOVAs). Although the two groups did not 
differ in terms of premorbid IQ, WTAR-predicted 
IQ correlated with some language measures and was 
therefore entered as a covariate. MANCOVA revealed 
that the patients’ connected speech performance was 
significantly more impaired than that of healthy 
controls, l  0.402, F(17,30)  2.631, p  0.01. Post 
hoc (Bonferroni-corrected) analyses of the univari-
ate contrasts showed that ALS patients produced a 
significantly lower mean number of words (p  .007), 
lower mean duration of narrative (p  .018), a higher 
mean number of distortions (p  .018), and more 
incomplete sentences (p  .009). Patients also pro-
duced a lower mean length of utterances (p  .004) 
and more semantic errors (p  .014).
To evaluate the contribution of a bulbar motor 
disorder, we identified mild dysarthria in three patients 
(ALSFRS-R (15) score on speech item  4). To min-
imize the possibility that language performance was 
influenced by dysarthria or verbal fluency, following 
the approach of earlier work (13) we separately anal-
ysed performance in the subset of 23 patients who did 
not have dysarthria and the 22 patients who did not 
have an impaired VFi. The main effect remained sig-
nificant in the subset of patients without dysarthria 
(l  0.229, F(17,26)  1.665, p  0.01) and in the 
subset of patients without impaired VFi (l  1.506, 
F(17, 30)  2.658, p  .036). Univariate contrasts 
showed that non-dysarthric ALS patients produced 
more distortions (p  .038), more incomplete sen-
tences (p  .040), lower mean length of utterances 
(p  .004), and more semantic errors (p  .029) than 
controls. ALS patients without impaired VFi also pro-
duced more distortions (p  .037), more incomplete 
sentences (p  .049), lower mean length of utterances 
(p  .004), and more semantic errors (p  .029). 
Measures of connected speech performance in ALS 
and controls are summarized in Table IV.
Formal standardized language testing
A MANCOVA (adjusted for premorbid IQ) showed 
that ALS patients’ performance on formal standard-
ized language tests was more impaired than that of 
healthy controls overall (l  0.605, F(7,38)  3.539, 
Table III. Means and standard deviations of individual measures of executive, memory and 
visuoperceptual functioning in ALS and controls.
Test
Raw score, Mean
(SD) Controls
Raw score, Mean 
(SD) ALS F* p
Executive function
Category Verbal fluency Index-Animals 1.95 1.02 2.41 1.38 1.057 .311
Category Verbal fluency Index-Food 1.89 1.30 2.05 1.55 .035 .854
S Words Verbal fluency Index 3.25 2.11 4.14 2.94 1.031 .317
4-Letter C Word Verbal Fluency index 9.67 4.86 13.40 8.33 2.986 .093
Hayling Latency 8.05 11.83 14.31 9.40 3.043 .090
TEA dual decrement 1.19 .67 2.17 2.51 4.249 .049
WCST Categories achieved 6.00 .000 5.13 1.89 4.476 .052
WCST trials to first category 19.18 14.84 17.06 9.48 .276 .602
Memory
CVLT free recall 51.19 9.94 50.38 8.84 .004 .950
CVLT short-delay free recall .69 1.27 2.08 1.05 4.524 .058
CVLT long-delay free recall .23 .80 .25 .87 .138 .712
CVLT long-delay cued recall .10 .86 2.08 1.04 .061 .807
Visuospatial ability
JLO 27.69 2.51 26.50 4.46 .912 .344
VOSP object decision 18.15 1.29 18.79 1.25 2.507 .120
VOSP position discrimination 19.65 .89 18.71 2.99 2.265 .139
TEA: Test of Everyday Attention; WCST: Computerized Wisconsin Card Sorting Test; CVLT: 
California Verbal Learning Test; JLO: Judgment of Line Orientation; VOSP: Visual Object and Space 
Perception Battery.
*ANCOVA adjusted for premorbid IQ.
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p  0.01. Univariate contrasts showed that, compared 
to controls, ALS patients made more errors (p  .019), 
completed fewer blocks (p  .020) and scored lower 
overall (p  .022) on the TROG. They also performed 
worse on the modified Token Test (p .001) and 
the KDT Test (p  .020). These results were also 
observed in the subset of patients without impair-
ment on VFi (l  0.789, F(10,36)  2.841, p  0.001) 
and the non-dysarthric patients (l  0.475, F(10, 
33)  3.645, p  0.002). Means and SDs of struc-
tured language tests in ALS and controls are 
summarized in Table V.
Relationship of language deficits with other measures
The relationship between deficits on the language 
measures with cognitive composites, apathy scores 
and other measures of motor functioning was inves-
tigated using a series of correlations in the patient 
group only. The group of all patients with ALS 
exhibited a correlation between duration of narrative 
and motor speech functioning as measured by 
ALSFRS-dysarthria score (r  .461, p  .018). This 
relationship did not survive when the dysarthric and 
the VFi-impaired patients were excluded. No other 
significant correlations were identified.
Discriminant analysis
A stepwise discriminant function analysis was 
performed to determine whether specific language 
measures could be used together to predict group 
membership (i.e. ALS or control). The measures 
that were included in the analysis were distortions, 
incomplete sentences, mean length of utterances, 
semantic errors, TROG standard score, the modified 
Table IV. Mean (SD) measures of connected speech production in all patients with ALS, patients with ALS without verbal-fluency 
impairment (VFi), non-dysarthric patients with ALS, and controls.
Controls
(n  26)
All ALS
(n  26)
ALS without 
dysarthria
(n  23)
ALS without verbal 
fluency impairment
(n  22)
Speech rate and speech errors
Total numbers of words 179.60 (76.10) 123.50** (58.20) 148.25 (61.53) 135.80 (45.88)
Total duration of narrative (in seconds) 80.48 (36.04) 60.62 * (22.65) 73.50 (23.03) 68.60 (20.99)
Speech rate (words per minute) 139.53 (28.16) 120.63 (33.08) 119.18 (33.92) 120.50 (35.12)
Distortions (per hundred words) .56 (.98) 1.48 * (1.72) 1.36 * (1.75) 1.44* (1.82)
Phonological paraphasias (per hundred words) .09 (.80) .25 (.87) .30 (.95) .28 (.96)
Disruptions to fluency
False starts (per hundred words) .04 (.18) .06 (.32) .07 (.35) .07 (.35)
Filled pauses (per hundred words) 3.75 (2.33) 4.34 (2.87) 4.50 (2.66) 4.36 (2.95)
Repaired sequences (per hundred words) .90 (.26) .90 (.94) .92 (.94) .89 (.94)
Incomplete sentences (per hundred words) .09 (.57) .45** (.57) .36 * (.50) .41* (.59)
Lexical content
Closed class words (proportion) .14 (.02) .14 (.06) .14 (.05) .14 (.073)
Pronouns (proportions) .34 (.09) .32 (.06) .47 (.06) .31 (.06)
Verbs (proportion) .48 (.06) .48 (.08) .45 (.08) .48 (.08)
Syntactic structure and complexity
Mean length of utterance 18.75 (4.09) 14.28** (4.79) 13.61** (4.48) 13.98 **(4.91)
Words in sentences (proportion) .11 (.16) .10 (.09) .09 (.03) .11 (.09)
Syntactic errors (per hundred words) 1.11 (1.30) .86 (.88) .95 (.92) .83 (.92)
Embeddings (per hundred words) .10 (.26) .09 (.21) .10 (.23) .06 (.20)
Semantic errors (per hundred words) .009 (.05) .30 * (.56) .36 * (.60) .32* (.60)
ALS differs from controls: *p, 0.01; ** p, 0.05.
Table V. Means (SD) of structured measures of language functioning in all patients with ALS, patients with ALS without verbal 
fluency impairment (VFi), non-dysarthric patients with ALS, and controls.
Controls
(n  26) M (SD)
All ALS
(n  26) M (SD)
ALS without 
dysarthria
(n  23) M (SD)
ALS without verbal 
fluency impairment
(n  22) M (SD)
MTT scores 14.88 (0.43) 13.44** (1.66) 13.15** (1.72) 13.26** (1.85)
GNT scores 23.76 (1.92) 22.42 (4.40) 22.85 (4.72) 22.35 (4.33)
BPVS 151.64 (23.13) 147.79 (17.59) 147.25 (18.81) 146.20 (18.65)
TROG errors .23 (.71) 1.11* (1.60) 1.35* (1.72) 1.40* (1.72)
TROG blocks completed 19.80 (.63) 18.96* (1.58) 18.75* (1.71) 18.70* (1.71)
TROG standard score 108.07 (2.99) 104.00* (7.48) 103.00* (8.05) 102.75* (8.09)
PPT 51.53 (.64) 50.92 (1.09) 50.95 (.99) 50.90 (1.20)
KDT 51.73 (.66) 50.07* (1.57) 50.15* (1.69) 50.05** (1.70)
MTT: modified Token Test; GNT: Graded Naming Test; BPVS: British Picture Vocabulary Scale; TROG: Test for the Reception 
of Grammar; PPT: Pyramids and Palm Trees Test; KDT: Kissing and Dancing Test.
ALS differs from controls: *p, 0.01; ** p, 0.05.
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Token Test score and KDT score. Our results showed 
that mean length of utterance was entered first, fol-
lowed by incomplete sentences and then the modi-
fied Token Test, with no other measures contributing 
significantly to discriminability. Ninety-six percent 
of healthy controls and 81.8% of all ALS patients 
were correctly classified (Wilks’ Lambda  .537, 
c2  28.28, p  0.001). These data suggest that the 
three language measures provide a sensitivity of 
81.8% and a specificity of 96%. When patients with 
dysarthria and executive (i.e. VFi) impairment were 
removed, the same model classified 96% of healthy 
controls and 85% of ALS patients accurately (Wilk’s 
lambda  .436, c2  34.489, p  0.001).
Discussion
The objective of this study was to clarify whether 
ALS patients without FTLD presented specific 
changes in connected speech production evident in 
a description of the Cookie Theft Picture, as well as 
other linguistic deficits as measured by a variety of 
other formal standardized language tests. The find-
ings of the present study are consistent with litera-
ture indicating expressive and receptive language 
disturbances in ALS (6,8–13). We found that patients 
with ALS showed deficits in speech production flu-
ency and in semantic and syntactic comprehension. 
Consistent with recent work (13) we also showed 
that syntactic and action knowledge deficits are inde-
pendent of motor speech impairments and that syn-
tactic features can be informative in distinguishing 
between ALS and healthy control groups. In previ-
ous studies (6,9,12,13) ALS patients had signifi-
cantly poorer executive performance than controls, 
while in ours they performed within the normal 
range. This difference across research samples might 
reflect the large variability within the ALS popula-
tion, and/or our stringent exclusion criteria. Research 
on less cognitively impaired patients is crucial to iso-
late the relationship between ALS and language 
impairment. Thus, on the assumption that our sam-
ple was on average less cognitively impaired than 
previous samples, the current results suggest that 
syntactic and semantic processing can deteriorate 
in ALS independently and/or earlier than other 
cognitive functions.
On the connected speech measures, patients with 
ALS were impaired on dimensions that contribute 
to fluency; they produced a lower number of words, 
a shorter duration of narrative and made more 
distortions. These deficits did not survive when the 
dysarthric ALS patients were excluded and were 
probably the consequence of motor speech deficits. 
Lexical content was not impaired in any of the 
subgroups of patients; however, many patients pro-
duced utterances that were not complete sentences 
and showed a reduced length of utterances and 
more semantic errors. These selective deficits in the 
absence of executive function difficulties suggest a 
syntactic complexity impairment, consistent with 
findings recently reported in the literature (13,36). 
Interestingly, these linguistic dysfunctions parallel 
the connected speech features of patients with PNFA 
reported by Wilson et al. (35).
Performance on structured standardized lan-
guage tests confirmed that ALS patients showed 
impairment in syntactic comprehension and seman-
tic/action knowledge, in agreement with previous 
studies (3,10,35,37), but were relatively unimpaired 
on tests of single word naming and comprehension 
of objects. Previous studies (6,9) reported confronta-
tion naming deficits in ALS but these were mild in 
clinical terms. Our findings again confirm the prop-
osition that ALS patients may have specific impair-
ments of the syntactic and action knowledge systems 
and also suggest that most of these deficits are not 
related to executive dysfunction. The present findings 
relating to sentence production are in agreement 
with others (13) but are set in the context of a more 
comprehensive assessment of language function, 
highlighting the sensitivity of these measures in 
detecting abnormalities. Difficulties in the mechan-
ics of language are a common characteristic in 
FTD-ALS with bulbar onset as well as PNFA. Our 
findings are consistent with previous research that 
has highlighted both overlap and independence of 
FTD and aphasia (6,38) and extend the finding 
of syntactic impairment in ALS patients with limb 
onset.
It is well known that Broca’s area is involved in 
the processing of sentence structure (39,40). Broca’s 
area is adjacent to motor areas such as the lower 
precentral gyrus. Yoshizawa et al. (36) found reduced 
activation in Broca’s area in ALS patients with syn-
tactic comprehension impairments. They proposed 
that in ALS, neurodegeneration first progresses from 
the medulla oblongata and pons to the prefrontal 
gyrus and Broca’s area. When neurodegeneration is 
limited to Broca’s area, syntactic comprehension 
impairments without executive dysfunction might 
occur. This pattern of degeneration could explain 
why executive and language dysfunction are strongly 
associated in ALS, and also why executive dysfunc-
tion cannot always account for the language impair-
ment observed. Further imaging studies are needed 
to determine the mechanisms by which neurodegen-
eration progresses in ALS and how these affect 
non-motor systems.
The results of our discriminant analysis con-
firmed that three measures of syntax may differen-
tiate between ALS and healthy controls. Two 
connected speech measures (i.e. mean length of 
utterance and incomplete sentences) were the 
strongest discriminating factors followed by spoken 
sentence comprehension. From a clinical point of 
view, progressively deteriorating bulbar symptoms 
make it difficult to evaluate language and especially 
speech functions in ALS. In the past, speech 
related problems in ALS may have been relatively 
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overlooked in linguistic research because evaluation 
of these features in ALS patients is difficult. In the 
present study, features of syntactic processing accu-
rately differentiated ALS patients from healthy con-
trols without being masked by dysarthria. Our 
findings suggest that syntactic processing deficits 
may be evident at the early stages of the disease and 
that these deficits can be detected by relatively sim-
ple language tests.
Most importantly, the recent interest in the 
cognitive changes in non-demented ALS has led to 
the publication of consensus criteria for optimum 
assessment of cognitive profile (41). These criteria 
recommend that non-demented patients with ALS 
be considered as cognitively impaired based solely 
on measures of executive functioning. Our findings 
are in agreement with Taylor et al. (6) and suggest 
that language dysfunction is an important aspect of 
the cognitive profiles of non-demented ALS patients 
that cannot always be explained by executive dys-
function. Failure to revise the current consensus 
criteria could lead to underestimates of the preva-
lence rates of cognitive impairment and the develop-
ment of less viable diagnostic, prognostic and 
monitoring markers.
The results of this study must be interpreted 
with caution due to the following limitations: 1) 
the small sample size; 2) the young average age of 
both groups; 3) the predominantly male sample; 4) 
the relatively mild motor impairment of the ALS 
patients; 5) the small number of bulbar-onset 
patients; and 6) the high intellectual ability of our 
participants. The pattern of language impairment 
reported in the present study relates only to rela-
tively unimpaired sporadic ALS patients and there-
fore the current study cannot comment on the 
general nature of language impairment in the wider 
ALS population. Finally, even though a wide range 
of executive function tests was incorporated, 
we cannot exclude the possibility that language 
performance could have been influenced by execu-
tive sub-functions (e.g. organization and sequenc-
ing) that have not been assessed in the present 
study.
Despite these limitations, the study confirms that 
independent linguistic deficits in ALS patients are 
present and these may be specific rather than global. 
It appears that the syntactic system is disrupted, 
while lexical access is relatively spared. This study 
has also provided the most comprehensive descrip-
tion of connected speech production in ALS to date. 
We showed that a detailed quantification of connected 
speech is necessary to characterize the linguistic 
changes of verbal expression in patients with ALS. 
The present study also proposes that the linguistic 
features derived from a simple picture description 
task can be clinically informative. As we previously 
highlighted (6), there is a need to reconsider the 
current consensus criteria (41) for the identification 
of cognitive impairment in ALS, in order to include 
language impairments as well as executive 
dysfunction. 
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